A2780CP Orthotopic Model


A2780CP is a cisplatin-resistant subline derived from A2780, a human ovarian cancer cell line. It represents a valuable model for studying drug resistance mechanisms in ovarian cancer and developing strategies to overcome treatment resistance. A2780CP exhibits resistance to cisplatin, a commonly used chemotherapeutic agent for ovarian cancer. Researchers utilize this cell line to investigate mechanisms underlying cisplatin resistance, explore alternative treatment options, and develop targeted therapies for resistant ovarian cancer.

Model Details

Cancer Type: Ovarian Cancer
Model Name: A2780CP
Mouse Strain: NCr Nude
Treatment Data Available: N/A

A2780/CP Survival

Survival of IP disseminated A2780/CP in NCr Nude mice (n=5) 

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content